Medline Inc.

Medline Inc.

MDLN

Get informed when a big investor buys or sells

+ Follow
Market Cap$34.7B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medline Inc.Medline Inc.33.9-9%1.11.1
$44.00

Target Price by Analysts

11.6% upsideMedline Target Price DetailsTarget Price
$52.91

Current Fair Value

34.2% upside

Undervalued by 34.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$34.70 Billion
Enterprise Value$45.04 Billion
Dividend Yield$- (-)
Earnings per Share$1.43
Beta-0.42
Outstanding Shares819,000,000

Return

Return on Equity8.55%ROE
Return on Assets2.47%
Return on Invested Capital5.52%

Valuation & Multiples

P/E Ratio33.92P/E Ratio
PEG-56.35PEG
Price to Sales1.13Price to Sales
Price to Book Ratio1.71Price to Book Ratio
Enterprise Value to Revenue1.55
Enterprise Value to EBIT22.39
Enterprise Value to Net Income46
Total Debt to Enterprise0.28
Debt to Equity1.12Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
June 3, 2026
EPS Estimate
$0.29
Average shareholder expectation
Revenue Estimate
$7.13 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$0.32
Average shareholder expectation
Revenue Estimate
$7.52 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 38.79%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.00% 78.39%
Total Invested$1.00M 100.00%
Investors Holding11 315.00%

ESG Score

No data

About Medline Inc.

43,000 employees
CEO: James Boyle

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medli...